Private and Public Investments in Biomedical Research

Maya M. Durvasula, Lisa Ouellette and Heidi Williams ()

No 28349, NBER Working Papers from National Bureau of Economic Research, Inc

Abstract: Recent policy attention has focused on proposals to reduce prices for drugs that have received public funding. From an implementation perspective, such policies rely on public disclosure of government support for research. In this paper, we highlight two conceptual problems with past attempts to measure these public disclosures, and construct a new data set which corrects for these problems. Our corrected measures suggest that under-reporting of public research support is less of an issue than previously thought.

JEL-codes: I1 O3 (search for similar items in EconPapers)
Date: 2021-01
New Economics Papers: this item is included in nep-hea
Note: AG EH PR
References: Add references at CitEc
Citations:

Published as Maya Durvasula & Lisa Larrimore Ouellette & Heidi Williams, 2021. "Private and Public Investments in Biomedical Research," AEA Papers and Proceedings, American Economic Association, vol. 111, pages 341-345, May.

Downloads: (external link)
http://www.nber.org/papers/w28349.pdf (application/pdf)

Related works:
Journal Article: Private and Public Investments in Biomedical Research (2021)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberwo:28349

Ordering information: This working paper can be ordered from
http://www.nber.org/papers/w28349

Access Statistics for this paper

More papers in NBER Working Papers from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().